Clinical Trial Update: BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BP-C1 in short-term treatment of metastatic breast cancer (Stage IV) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BP-C1

Snippet

Sponsor: Meabco A/S | Conditions: Metastatic Breast Cancer, Stage IV Breast Cancer | Phase 2 | Status: COMPLETED